Health and economic impact of the seasonal influenza vaccination programme in England

Vaccine

Volumn 30, Issue 23, 2012, Pages 3459-3462

  Baguelin, Marc ^a,b   Jit, Mark ^a,b   Miller, Elizabeth ^a   Edmunds, William John ^a,b  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Cost effectiveness; Influenza; Vaccine

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONSULTATION; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; GROUPS BY AGE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITALIZATION COST; HUMAN; INFECTION PREVENTION; INFLUENZA VACCINATION; INFLUENZA VIRUS; MEDICAL FEE; MODEL; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SCHOOL CHILD; SEASONAL INFLUENZA; SEASONAL VARIATION; VIRUS STRAIN; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; ENGLAND; FEMALE; HUMANS; INCIDENCE; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MODELS, STATISTICAL; VACCINATION; YOUNG ADULT;

EID: 84859866302     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.03.019     Document Type: Article

References (22)

1. The macro-epidemiology of influenza vaccination in 56 countries, 1997-2003. Vaccine 2005, 23(October (44)):5133-5143.
2. Turner D., Wailoo A., Nicholson K., Cooper N., Sutton A., Abrams K. Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. Health Technol Assess 2003, 7(35):iii-iii, 1.
3. Turner D.A., Wailoo A.J., Cooper N.J., Sutton A.J., Abrams K.R., Nicholson K.G. The cost-effectiveness of influenza vaccination of healthy adults 50-64 years of age. Vaccine 2006, 24(February (7)):1035-1043.
4. Esposito S., Marchisio P., Bosis S., Lambertini L., Claut L., Faelli N., et al. Clinical and economic impact of influenza vaccination on healthy children aged 2-5 years. Vaccine 2006, 24(January (5)):629-635.
5. Marchetti M., Kuhnel U.M., Colombo G.L., Esposito S., Principi N. Cost-effectiveness of adjuvanted influenza vaccination of healthy children 6 to 60 months of age. Hum Vaccin 2007, 3(January (1)):14-22.
6. Baguelin M., Hoek A.J., Jit M., Flasche S., White P.J., Edmunds W.J. Vaccination against pandemic influenza A/H1N1v in England: A real-time economic evaluation. Vaccine 2010, (January).
7. Joseph C., Goddard N., Gelb D. Influenza vaccine uptake and distribution in England and Wales using data from the general practice research database, 1989/90-2003/04. J Public Health (Oxf) 2005, 27(December (4)):371-377.
8. Fleming D.M., Andrews N.J., Ellis J.S., Bermingham A., Sebastianpillai P., Elliot A.J., et al. Estimating influenza vaccine effectiveness using routinely collected laboratory data. J Epidemiol Community Health 2010, 64(December (12)):1062-1067.
9. Jefferson T., Di Pietrantonj C., Rivetti A., Bawazeer G.A., Al Ansary L.A., Ferroni E. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2010, (7):CD001269.
10. Carrat F., Vergu E., Ferguson N.M., Lemaitre M., Cauchemez S., Leach S., et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008, 167(April (7)):775-785.
11. Meier C.R., Napalkov P.N., Wegmuller Y., Jefferson T., Jick H. Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom. Eur J Clin Microbiol Infect Dis 2000, 19(November (11)):834-842.
12. Pitman R.J., Melegaro A., Gelb D., Siddiqui M.R., Gay N.J., Edmunds W.J. Assessing the burden of influenza and other respiratory infections in England and Wales. J Infect 2007, 54(June (6)):530-538.
13. Tilston N.L., Eames K.T., Paolotti D., Ealden T., Edmunds W.J. Internet-based surveillance of influenza-like-illness in the UK during the 2009 H1N1 influenza pandemic. BMC Public Health 2010, 10:650.
14. Kind P., Dolan P., Gudex C., Williams A. Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ 1998, 316(March (7133)):736-741.
15. National Institute for Health and Clinical Excellence Updated guide to the methods of technology appraisal June 2008, National Institute for Health and Clinical Excellence, London, Available at: www.nice.org.uk/media/B52/A7/TAMethodsGuideUpdatedJune2008.pdf [accessed on 11 August 2010].
16. Jit M., Cromer D., Baguelin M., Stowe J., Andrews N., Miller E. The cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and Wales. Vaccine 2010, 29(December (1)):115-122.
17. Tan-Torres Edejer T., Baltussen R., Adam T., Hutubessy R., Acharya A., Evans D.B., Murray C.J.L. Making choices in health: WHO guide to cost-effectiveness analysis 2003, World Health Organisation, Geneva.
18. Jick H., Hagberg K.W. Effectiveness of influenza vaccination in the United kingdom, 1996-2007. Pharmacotherapy 2010, 30(December (12)):1199-1206.
19. Donaldson L.J., Rutter P.D., Ellis B.M., Greaves F.E., Mytton O.T., Pebody R.G., et al. English mortality from A/H1N1. Comparisons with recent flu mortality. BMJ 2010, 340:c612.
20. Flu Watch Consortium Community study of influenza transmission and immunity 2011, Available at: http://www.idrn.org/documents/events/presentations/pandemic/Andrew%20Hayward.pdf [accessed on 11 November 2011].
21. Curtis L. Unit costs of health and social care 2009, Personal Social Services Research Unit, University of Kent at Canterbury, Kent, Available at: http://www.pssru.ac.uk/uc/uc2009.htm [accessed on 27 December 2009].
22. van Hoek A.J., Underwood A., Jit M., Miller E., Edmunds W.J. The impact of pandemic influenza H1N1 on health-related quality of life: a prospective population-based study. PLoS One 2011, 6(3):e17030.